CNS Pharma @cns_pharma Twitter profile

Last Seen Profiles

@hope_eats

@NUMFON__19

@DYLAN_00000000

@Cagdastok

@Peaceful__rebel

@AfafAziz1970

@IbDoku

@magicccat

@Brento418

@ChateauVLV

@MwtbgthHotbedj

@fonsaberry

@terpolv

@Owain_Jones_

@benjit14

@LanishaMi19790

@bokeplokalmalam

@oekakibananami

@nelscline

@hecilvenanciog1

@DaveHerrell

@AkronWkro

@scenerice

@Adeztapas04

@draft_kaigi

@LeSiboire

@motivacion

@KarenaArrazola

@ShufraJudaica

@strcwbrryie

@TrillVille1337

@IvasiTV

@ORTEGZcom

@kelaeke

@sambjorling

@WulandaNeng

CNS Pharma

@cns_pharma

3 years

Did you have a chance to view our interview with @proactive_na ? $CNSP

CNS Pharmaceuticals begins enrollment for a Phase 2 clinical study to...

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO John Climaco tells Proactive the Houston, Texas-based biopharmaceutical company has begun enrollment for its Pha...

www.youtube.com

8

3

59

CNS Pharma

@cns_pharma

4 years

It’s #BrainAwarenessWeek ! $CNSP is proud to be working in the neuroscience space and remain dedicated to our mission of hope for all #BrainTumor patients. #BrainWeek #Glioblastoma #GlioblastomaMultiforme #GBM

1

10

38

CNS Pharma

@cns_pharma

4 years

$CNSP Set to Begin Enrolling Brain Cancer Drug Trial Participants

3

5

33

CNS Pharma

@cns_pharma

3 years

#GlioblastomaMultiforme remains a significant unmet medical need. $CNSP #GBM #Oncology #GBMAwareness

4

7

33

CNS Pharma

@cns_pharma

4 years

Industry News: Duke Neurology Research Round Up, March 2021 #glioblastoma #neuro -oncology” #braincancer

4

30

CNS Pharma

@cns_pharma

4 years

BioMedNewsBreaks – $CNSP Set to Start Potentially Pivotal Berubicin Trial

2

1

25

CNS Pharma

@cns_pharma

3 years

#GBM is one of the most aggressive, deadly and treatment-resistant cancers that form in the brain. $CNSP #GBM #GlioblastomaMultiforme #Oncology

2

3

24

CNS Pharma

@cns_pharma

3 years

$CNSP continues to build upon our clinical development expertise, with the hope to develop additional potential treatment options for multiple #oncology indications. #CNSCancer #CNSTumors

0

2

19

CNS Pharma

@cns_pharma

1 year

Our CEO, John Climaco, provides a corporate overview at the recent Virtual Investor Summer Spotlight Series. Access the full video webcast replay here: $CNSP @InvestorVirtual #GlioblastomaMultiforme #GBM #Oncology

3

1

21

CNS Pharma

@cns_pharma

3 years

Our CEO, John Climaco, highlights the severe unmet medical need in #glioblastoma and our commitment to the #GBM patient community. $CNSP #GBMDay #GlioblastomaMultiforme #GBMAwareness #BTSM

1

2

23

CNS Pharma

@cns_pharma

4 years

Our innovative anthracycline, Berubicin, has demonstrated clinical response in #GBM patients, and we look forward to advancing its development. $CNSP #Glioblastoma #GlioblastomaMultiforme

1

8

20

CNS Pharma

@cns_pharma

4 years

It’s #BrainAwarenessWeek ! $CNSP encourages you to visit @dana_fdn website for a full array of resources to keep you up to date on the latest news, research findings, and more! #BrainWeek #Glioblastoma #GlioblastomaMultiforme #GBM

1

4

19

CNS Pharma

@cns_pharma

4 years

#CNSInTheNews — John Climaco, CEO of CNS Pharmaceuticals, Discusses New Treatment for Glioblastoma Take a look at this in-depth discussion with our CEO, John Climaco and @mydocwire : #CNSP #berubicin

1

2

17

CNS Pharma

@cns_pharma

4 years

BioMedNewsBreaks – $CNSP Berubicin Continues to Advance Toward Clinical Trials

0

2

17

CNS Pharma

@cns_pharma

4 years

In recognition of #NationalCancerPreventionMonth we encourage you to check out these easy tips from the CDC for a #healthylifestyle and #cancerprevention . $CNSP @CDC_Cancer

1

14

CNS Pharma

@cns_pharma

4 years

As we approach the end of #NationalCancerPreventionMonth , don’t forget to take a few minutes to read about #cancerprevention and early detection from the CDC. $CNSP @CDC_Cancer

1

2

11

CNS Pharma

@cns_pharma

1 year

John Climaco, CEO of CNS Pharmaceuticals, walks us through what happens after the Company’s interim analysis. To watch the entire webcast replay of the Virtual Investor Summer Spotlight Series, visit $CNSP #GlioblastomaMultiforme #GBM #Oncology

1

11

CNS Pharma

@cns_pharma

4 years

Don’t miss it! $CNSP is presenting today at the @HCWCO Global Life Sciences Conference. To view the webcast, click here: $CNSP #HCWEvents #GlioblastomaMultiforme #GlioblastomaTumor #GBM

0

11

CNS Pharma

@cns_pharma

3 years

Our lead program #Berubicin has the potential to be the first #anthracycline to cross the blood-brain barrier and is designed to concentrate in tumor tissue. $CNSP

0

4

10

CNS Pharma

@cns_pharma

4 years

Industry News: Recurrent Glioblastoma Brain Tumors With Fewer Mutations Respond Better to Immunotherapy #glioblastoma #neuro -oncology” #braincancer

0

1

8

CNS Pharma

@cns_pharma

3 years

Zena Muzyczenko, Global Director of Clinical Operations for $CNSP, is proud to shine a light on #GBMawarenessday . #Glioblastoma #GBMDay @NBTStweets #GlioblastomaMultiforme

2

3

8

CNS Pharma

@cns_pharma

3 years

With the necessary regulatory approvals in Switzerland, our team is working diligently to bring clinical sites online. $CNSP #Glioblastoma #GBM #GlioblastomaMultiforme #Oncology

0

3

8

CNS Pharma

@cns_pharma

2 years

Industry News: A Closer Look at Glioblastoma and New Reasons for Hope #braincancer #glioblastoma #neuro -oncology

A Closer Look at Glioblastoma and New Reasons for Hope

Approximately 15,000 Americans will be diagnosed with glioblastoma this year. Although considered a rare cancer, doctors are seeing an increase in cases of the aggressive and deadly brain cancer...

www.nbcwashington.com

0

5

7

CNS Pharma

@cns_pharma

3 years

CNS Pharmaceuticals Receives Approval from Competent Authority of Switzerland for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM). $CNSP #Glioblastoma #GBM #oncology #GlioblastomaMultiforme

0

3

8

CNS Pharma

@cns_pharma

3 years

Sunday is dedicated for survivors, to #celebratelife and inspire those fighting. To learn more and get involved please visit: $CNSP @SurvivorsDay #NCSD2021 #Oncology #Glioblastoma #BrainTumors

0

8

CNS Pharma

@cns_pharma

4 years

Our CEO, John Climaco, speaks to the Company’s dedicated mission of not only providing hope for #Glioblastoma patients but also a safe and effective treatment option. #RareDiseaseDay #ShowYourStripes #CareAboutRare

1

0

8

CNS Pharma

@cns_pharma

3 months

Today is #GlioblastomaAwarenessDay . Today, we amplify the voices, experiences, and urgent needs of everyone living with #glioblastoma , the most common, complex, treatment-resistant, and deadliest type of brain cancer. Learn more: $CNSP #GBM #Oncology

0

2

8

CNS Pharma

@cns_pharma

3 years

FDA Grants Fast Track Designation to $CNSP for Berubicin for the Treatment of Recurrent #GlioblastomaMultiforme . #Glioblastoma #GBM #Oncology

0

1

7

CNS Pharma

@cns_pharma

3 years

Industry News: All GA-binding Proteins Shown To Have The Highest Expression Levels In Secondary Glioblastomas #braincancer #glioblastoma #neuro -oncology

Study: All GA-binding proteins have the highest expression levels in secondary glioblastomas

Oncotarget published "TERT and its binding protein: overexpression of GABPA/B in high grade gliomas" which reported that all GA-binding proteins progress through the glioma grades and have the...

www.news-medical.net

0

3

7

CNS Pharma

@cns_pharma

4 years

Industry News: Glioblastoma Gene Discovery At University Of Virginia In The Running For Award #glioblastoma #neuro -oncology” #braincancer

Glioblastoma gene discovery at UVA in the running for award

University of Virginia School of Medicine researchers are in the running for a big award, after discovering a gene that is responsible for causing one of the deadliest cancers.

www.29news.com

0

1

7

CNS Pharma

@cns_pharma

4 years

Industry News: John Climaco, CEO of CNS Pharmaceuticals, Discusses New Treatment for Glioblastoma #globlastoma #neuro -oncology” #braincancer

1

2

6

CNS Pharma

@cns_pharma

4 years

BioMedNewsBreaks – $CNSP Leverages ‘Absolute Powerhouse Compound’ as IND Status Paves Way for Clinical Trials

0

7

CNS Pharma

@cns_pharma

2 years

We are committed to advancing our development pipeline to provide a much-needed potential therapy option for #Glioblastoma patients. $CNSP #GlioblastomaMultiforme #GBM #Oncology

1

2

6

CNS Pharma

@cns_pharma

3 years

Industry News: Glioblastoma Therapy May Be Improved by Targeting Specific Enzyme #glioblastoma #neuro -oncology” #braincancer

Glioblastoma Therapy May Be Improved by Targeting Specific Enzyme

Researchers believe that focusing on MCFA catabolism could exploit a key metabolic feature of an aggressive form of brain and spinal cord cancer.

www.genengnews.com

0

2

7

CNS Pharma

@cns_pharma

2 years

We are proud to sponsor this year’s International Conference on Brain Tumor Research and Therapy 2023 hosted by @Dukeneurosurg ! For more information on the conference, visit: #GlioblastomaMultiforme #GBM #Oncology #ICBTRT2023 $CNSP

1

3

7

CNS Pharma

@cns_pharma

2 months

Receiving a diagnosis of glioblastoma multiforme is devastating news for patients and their families and we are dedicated to supporting patients and their families throughout their cancer journey. $CNSP #GlioblastomaMultiforme #GBM #Oncology

1

0

7

CNS Pharma

@cns_pharma

3 years

Industry News: US Food and Drug Administration Regulatory Updates In Neuro-Oncology – Report #braincancer #glioblastoma #neuro -oncology

0

2

7

CNS Pharma

@cns_pharma

2 years

CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM. #GlioblastomaMultiforme #GBM #Oncology $CNSP

0

1

7

CNS Pharma

@cns_pharma

3 years

$CNSP Gains Inclusion on Russell 2000 Index as Brain Cancer Trial Enrollment Advances

0

7

CNS Pharma

@cns_pharma

3 years

We are a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. $CNSP #GlioblastomaMultiforme #GBM

1

5

6

CNS Pharma

@cns_pharma

3 years

CNS Pharmaceuticals Receives Approval from France Ethics Committee and Competent Authority for Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM). $CNSP #Glioblastoma #GlioblastomaMultiforme #GBM

0

1

6

CNS Pharma

@cns_pharma

3 months

CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series $CNSP @InvestorVirtual #GBM #Oncology #GlioblastomaMultiforme #BrainTumors

1

3

6

CNS Pharma

@cns_pharma

3 years

Industry News: Tumor Ablation Market Share Growing Rapidly with Recent Trends and Outlook 2026 By Reports And Data #braincancer #glioblastoma #neuro -oncology

1

4

6

CNS Pharma

@cns_pharma

3 years

Industry News: Naked Mole Rats May Hold Key To Treating Cancer And Dementia #braincancer #glioblastoma #neuro -oncology

0

2

6

CNS Pharma

@cns_pharma

4 years

Industry News: The Zika Virus Can Activate Immune Cells To Destroy Glioblastoma #glioblastoma #neuro -oncology” #braincancer

Zika virus helps kill deadly brain cancer in mice

A study with mice shows that the Zika virus can rev up the immune system to destroy glioblastoma, a deadly form of brain cancer.

www.futurity.org

0

6

CNS Pharma

@cns_pharma

4 years

Industry News: Polyamines Drive Myeloid Cell Survival By Buffering Intracellular Ph To Promote Immunosuppression In Glioblastoma #glioblastoma #neuro -oncology” #braincancer

0

1

6

CNS Pharma

@cns_pharma

4 years

Industry News: German Scientists Complete First Human Test of Vaccine Against Brain Cancer #glioblastoma #neuro -oncology” #braincancer

Scientists Complete First Human Test of Vaccine Against Brain Cancer

German scientists have tested a special vaccine targeted at helping the body fight brain cancers for the first time in humans.

futurism.com

0

1

6

CNS Pharma

@cns_pharma

4 years

BioMedNewsBreaks – $CNSP on the Verge of Changing History with Berubicin

0

6

CNS Pharma

@cns_pharma

3 years

Industry News: Treating Brain Cancer With Drug Previously Used On Canines #braincancer #glioblastoma #neuro -oncology

0

5

CNS Pharma

@cns_pharma

1 year

Have you seen our latest presentation? Check it out here: $CNSP #GlioblastomaMultiforme #GBM #Oncology

0

1

6

CNS Pharma

@cns_pharma

1 year

Our lead product candidate is being developed as a potential treatment option for glioblastoma. Learn more here: $CNSP #BrainTumorAwarenessMonth #GlioblastomaMultiforme #GBM #Oncology #BTAM

1

6

CNS Pharma

@cns_pharma

2 years

CNS Pharmaceuticals Announces Dosing of First Patient in Europe/France in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM. $CNSP #GlioblastomaMultiforme #GBM #Oncology

0

2

6

CNS Pharma

@cns_pharma

3 years

We have a dedicated team of professionals working to advance our therapeutic pipeline. $CNSP #Oncology #Glioblastoma #GBM #BrainCancer @InvestorVirtual #VirtualInvestor

1

2

6

CNS Pharma

@cns_pharma

3 years

Industry News: Aggressive Brain Tumor In Children Can Be Identified By Analyzing Cerebrospinal Fluid #braincancer #glioblastoma #neuro -oncology

0

1

5

CNS Pharma

@cns_pharma

4 years

Industry News: New Immunotherapy Helps Man Live Longer With Brain Cancer #glioblastoma #neuro -oncology” #braincancer

'This is unreal': New Immunotherapy Helps Man Live Longer With Brain Cancer

Immunotherapy helps immune systems fight cancer.

spectrumlocalnews.com

0

2

6

CNS Pharma

@cns_pharma

3 years

Industry News: Scientists Discover How Molecule Becomes Anticancer Weapon #braincancer #glioblastoma #neuro -oncology

Scientists Discover How Molecule Becomes Anticancer Weapon

The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat glioblastoma, a brain cancer. Scientists now for the first time understand the enzyme-driven...

scripps.ucsd.edu

0

1

6

CNS Pharma

@cns_pharma

1 year

This May, we come together for #BrainTumorAwarenessMonth — a month dedicated to supporting, empowering, and amplifying the voice of the brain tumor community. $CNSP #GrayMay #BTAM #GlioblastomaMultiforme #GBM #Oncology @NBTStweets

1

0

6

CNS Pharma

@cns_pharma

3 years

Industry News: Cure For Deadly Brain Cancer May Be On Its Way #glioblastoma #neuro -oncology” #braincancer

0

1

6

CNS Pharma

@cns_pharma

4 years

Industry News: Awake Brain Surgery Helps Cancer Patient #glioblastoma #neuro -oncology” #braincancer

1

0

6

CNS Pharma

@cns_pharma

2 years

Today marks the beginning of Brain Awareness Week! Brain Awareness Week is the global campaign to foster awareness, enthusiasm and support for brain science. Learn more here: $CNSP #brainawarenessweek2023 #BrainWeek

0

2

6

CNS Pharma

@cns_pharma

3 years

$CNSP #2021ScorecardSeries : October 11, 2021: Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme. . #GBM #Oncology #GBMAwareness

0

4

6

CNS Pharma

@cns_pharma

2 months

#HappeningNextWeek : Virtual Investor CEO Connect Featuring CNS Pharmaceuticals Monday, August 26 at 12 PM ET! Pre-submit your questions to cnsp @jtcir .com and register for the webcast here: $CNSP @investorvirtual #GlioblastomaMultiforme #GBM #Oncology

1

0

5

CNS Pharma

@cns_pharma

4 years

Industry News: New Combination Treatment Approach Improves Overall Survival In Mice With Glioblastoma #glioblastoma #neuro -oncology” #braincancer

0

1

5

CNS Pharma

@cns_pharma

3 years

BioMedNewsBreaks – $CNSP Receives Fast Track Designation for Lead Investigational Drug

0

2

5

CNS Pharma

@cns_pharma

3 years

CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook $CNSP #oncology #glioblastoma #GBM

0

3

5

CNS Pharma

@cns_pharma

2 years

Industry News: Treatment To Boost White Blood Cells May Benefit Patients With Glioblastoma #braincancer #glioblastoma #neuro -oncology

Treatment to boost white blood cells may benefit patients with glioblastoma

A new study led by Washington University School of Medicine in St. Louis reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential...

www.news-medical.net

0

4

CNS Pharma

@cns_pharma

4 years

Industry News: Cleveland's University Hospitals Uses Targeted Radiation To Improve Post-Brain Cancer Surgery Results #glioblastoma #neuro -oncology” #braincancer

0

5

CNS Pharma

@cns_pharma

3 months

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO ASCO CNS Cancer Conference $CNSP #GBM #BrainTumors #GlioblastomaMultiforme

1

0

5

CNS Pharma

@cns_pharma

3 years

Industry News: U.S. Senate Passes Glioblastoma Awareness Day Resolution #glioblastoma #neuro -oncology” #braincancer

0

5

CNS Pharma

@cns_pharma

4 years

Industry News: Brain Tumor Center Launched at Yale #glioblastoma #neuro -oncology” #braincancer

Chênevert Family Brain Tumor Center Launched at Yale

Yale School of Medicine announces a gift to establish the Chênevert Family Brain Tumor Center at Yale Cancer Center. The Chênevert Family Brain Tumor Center

medicine.yale.edu

0

5

CNS Pharma

@cns_pharma

2 years

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting. $CNSP @ASCO #ASCO22 #Glioblastoma #GlioblastomaMultiforme #GBM #oncology

0

1

4

CNS Pharma

@cns_pharma

3 years

Industry News: Drug Modifies DNA Methylome in Aggressive Brain Tumors #braincancer #glioblastoma #neuro -oncology

0

2

5

CNS Pharma

@cns_pharma

5 years

This morning we are excited to announce FDA filing for our brain cancer drug! To read the details about this important development, click here: $CNSP #BRAINCANCER #GLIOBLASTOMA #NASDAQ #FDA #ORPHANDRUG

0

2

5

CNS Pharma

@cns_pharma

3 years

Tune in for our live presentation at the Virtual Investor Spotlight Series at 11:30 AM ET. Access the event here: $CNSP @InvestorVirtual #GBM #Glioblastoma

0

1

5

CNS Pharma

@cns_pharma

3 months

We are focused on developing novel drugs with the ultimate aim of advancing treatments for patients with brain cancers. $CNSP #GlioblastomaMultiforme #GBM #Oncology

5

0

5

CNS Pharma

@cns_pharma

3 years

We are excited to have commenced patient enrollment in our potentially pivotal study of Berubicin. $CNSP #GBM #Glioblastoma #BrainCancer #Oncology

0

5

CNS Pharma

@cns_pharma

3 years

Industry News: No Link Between Cell Phones and Brain Tumors in Large UK Study #braincancer #glioblastoma #neuro -oncology

No Link Between Cell Phones and Brain Tumors in Large UK Study

A large UK study has found no link between brain tumors and cell phone use, even among individuals who used them daily and for more than 10 years.

www.medscape.com

0

5

CNS Pharma

@cns_pharma

2 years

Industry News: Research Suggests A New Approach To Treat Glioblastoma Multiforme, A Form Of Brain Cancer #braincancer #glioblastoma #neuro -oncology

0

3

5

CNS Pharma

@cns_pharma

3 years

Industry News: University of Alabama Researcher Awarded $3.09 Million R01 To Study Drug Targets For Glioblastoma #braincancer #glioblastoma #neuro -oncology

Miller awarded $3.09 million R01 to study drug targets for glioblastoma

The grant will fund research surrounding next-generation human models that could potentially aid in the development of treatment for glioblastoma.

www.uab.edu

0

3

5

CNS Pharma

@cns_pharma

3 years

Industry News: Searching for a Cure for Deadly Brain Tumors #braincancer #glioblastoma #neuro -oncology

Searching for a Cure for Deadly Brain Tumors - Neuroscience News

Researchers are currently recruiting patients for a Phase 1 trial of a new immunotherapy treatment for glioblastoma brain cancer.

neurosciencenews.com

0

3

5

CNS Pharma

@cns_pharma

3 years

Industry News: For Glioblastoma, New Clinical Trial Advances Basic Science Research On The Relationship Between Purine Levels And Treatment Resistance #braincancer #glioblastoma #neuro -oncology

0

2

5

CNS Pharma

@cns_pharma

1 year

Our CEO, John Climaco, gives an overview of #GlioblastomaMultiforme and what $CNSP is doing to have a positive impact on the future of #GBM patients. #Oncology #BrainTumorAwarenessMonth #GrayMay

1

5

CNS Pharma

@cns_pharma

3 years

Industry News: Tumor-promoting Immune Cells Retrained To Fight Most Aggressive Type Of Brain Cancer #braincancer #glioblastoma #neuro -oncology

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine gliobl...

Nature Communications - Glioblastomas (GBM) are frequently resistant to immune checkpoint blockade therapy. Here the authors show that treatment with an agonistic anti-GITR antibody converts tumor...

www.nature.com

0

4

CNS Pharma

@cns_pharma

4 years

#GBMDayAwareness — CNS Pharmaceuticals Recognizes Glioblastoma Awareness Day Read our official announcement and work everyday in the fight against #FightGBM here: #CNSAdvocates #Glioblastoma

0

4

CNS Pharma

@cns_pharma

3 years

Dr. Sandra Silberman, Chief Medical Officer of $CNSP, highlights our lead program and the data seen to date. #Oncology #Glioblastoma #GBM #BrainCancer @InvestorVirtual #VirtualInvestor

1

0

5

CNS Pharma

@cns_pharma

3 months

We are pleased to be presenting at the SNO/ASCO CNS Metastases Conference in Denver, CO! $CNSP #GlioblastomaMultiforme #GBM #Oncology @ASCO

1

5

CNS Pharma

@cns_pharma

3 years

$CNSP #2021ScorecardSeries : September 30, 2021: Dosed First Group of Patients with Berubicin, an FDA-Designated Fast Track Drug Candidate, in the Potentially Pivotal Study for the Treatment of Glioblastoma Multiforme (GBM). . #GBM #Oncology #GBMAwareness

0

1

5

CNS Pharma

@cns_pharma

2 years

CNS Pharmaceuticals a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system malignancies. $CNSP #GlioblastomaMultiforme #GBM #Oncology

0

1

5

CNS Pharma

@cns_pharma

4 years

Industry News: New Combination Treatment Approach Improves Overall Survival In Mice With Glioblastoma #glioblastoma #neuro -oncology” #braincancer

1

5

CNS Pharma

@cns_pharma

3 years

Industry News: Effect of COVID-19 mRNA Vaccine On In Vitro Glial Cells Of The Brain Studied By Raman Spectroscopy And Imaging #braincancer #glioblastoma #neuro -oncology

0

3

5

CNS Pharma

@cns_pharma

3 years

Industry News: Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles #braincancer #glioblastoma #neuro -oncology

0

2

5

CNS Pharma

@cns_pharma

4 years

$CNSP New Investor Presentation Shows Value-Added Milestones for Berubicin in 2021

1

0

5

CNS Pharma

@cns_pharma

3 years

Industry News: 10 Important Clinical Advances in Cancer at MSK #braincancer #glioblastoma #neuro -oncology

0

3

5

CNS Pharma

@cns_pharma

3 years

Dr. Sandra L. Silberman, Chief Medical Officer of $CNSP, provides an overview of the current treatment landscape for #glioblastoma patients. Watch the full video at . #VirtualInvestor #GlioblastomaMultiforme #GBM @InvestorVirtual

1

6

5

CNS Pharma

@cns_pharma

3 years

Industry News: Predicting Brain Cancer Outcome #braincancer #glioblastoma #neuro -oncology

0

2

5

CNS Pharma

@cns_pharma

3 years

John Climaco, CEO of $CNSP, reflects on how far the Company has come over the past two years. #Oncology #Glioblastoma #GBM #BrainCancer @InvestorVirtual #VirtualInvestor

0

5

CNS Pharma

@cns_pharma

4 years

Industry News: Medical Imaging Market Analysis including Growth Factors #glioblastoma #neuro -oncology” #braincancer

0

1

5

CNS Pharma

@cns_pharma

4 years

$CNSP to Participate in Inaugural Emerging Growth Virtual Conference. @MaximGrp #EmergingGrowth

0

1

5

CNS Pharma

@cns_pharma

3 years

Industry News: Newly Developed Gel Helps Improve The Effectiveness Of Immunotherapy In Glioblastoma #braincancer #glioblastoma #neuro -oncology

Newly developed gel helps improve the effectiveness of immunotherapy in glioblastoma

Pairing a newly developed gel with immunotherapy that was delivered to post-surgical mouse brains with glioblastoma, a highly malignant and deadly cancer, improved the immunotherapy's effectiveness,...

www.news-medical.net

0

5

CNS Pharma

@cns_pharma

4 years

$CNSP Berubicin Trial is On Schedule to Commence in March 2021. #GlioblastomaMultiforme #Glioblastoma #Berubicin #BrainCancer

1

5